Actualités

Seagate heads into fiscal Q4 2026 earnings with AI-driven storage demand, rising HAMR adoption and margin gains that could support another earnings beat.

Tesla just shed 18% in a week after a earnings report that broke nearly every metric bulls were counting on, and now the question is whether the dip is a rare opportunity or a value trap disguised as a discount.

NextEra Energy reported another strong quarter.

Intel's (INTC) second-quarter revenue and earnings beat, along with above-consensus third-quarter gu

Selective Insurance beats Q2 earnings estimates as stronger investment income and underwriting lift results, while raising its 2026 investment income outlook.

INCY heads into Q2 earnings with strong Jakafi demand, Opzelura momentum and rising royalties, fueling expectations for an earnings beat.

The agreement gives CN new operating rights across key U.S. corridors in the Midwest and South while addressing some STB competition concerns.

Ford faces lower Q2 sales and EV weakness, but cost controls, product mix and valuation support its long-term case as investors await clearer guidance.

Security and Aerospace company Lockheed Martin (NYSE:LMT) announced better-than-expected revenue in Q2 CY2026, with sales up 10.5% year on year to $20.06 billion. The company’s full-year revenue guidance of $80.75 billion at the midpoint came in 2% above analysts’ estimates. Its GAAP profit of $7.94 per share was 10.4% above analysts’ consensus estimates.

Intel stock (INTC), which initially surged following its second quarter earnings yesterday, is trying to hold onto some of its gains Friday morning. Morning Brief Host Julie Hyman is joined by Yahoo Finance Senior Business Reporter Ines Ferré and Interactive Brokers chief strategist Steve Sosnick to discuss Intel's earnings release, outlook, and performance of its various business segments.

FIX posts a Q2 earnings and revenue beat as strong demand, margin expansion and record backlog growth reinforce confidence in its business momentum.

In the past few days, AT&T reported Q2 2026 results showing revenue of US$31.56 billion and net income of US$4.63 billion, alongside continued growth in fiber, fixed wireless and postpaid phone subscribers. Management also raised its 2026 share repurchase goal to about US$10 billion, signaling increased emphasis on buybacks as part of its broader convergence and capital return plans. Next, we’ll examine how AT&T’s stronger-than-expected earnings and accelerated buybacks interact with its...

DK, PBF and ALL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 24, 2026.

Eli Lilly's retatrutide meets the primary endpoint in the phase III TRIUMPH-2 & TRIUMPH-3 studies, supporting planned regulatory submissions for obesity in 2027.

IonQ has the most accurate quantum computing technology.

Dell's shares popped 10% on Wednesday following positive AI reports from analysts.

American Express (NYSE:AXP) stock is sliding Friday morning, trading at $320.55 and down 6% after the card issuer reported a Q2 2026 beat that traders opted to fade. The reaction hit within an hour of the 8:30 a.m. ET 8-K Form, pulling American Express stock down from a prior close of $340.84. The drop extends ... American Express Sinks 6% After Q2 Earnings Beat as Visa, Mastercard Hold Steady

TECK crushes Q2 estimates as higher copper and zinc prices, stronger sales volumes and margin expansion drive earnings and revenues sharply higher.

RBC Bearings (RBC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RTX tops Q2 earnings estimates and boosts full-year 2026 outlook as commercial aerospace, defense demand, and a record backlog fuel strong growth.

The average of price targets set by Wall Street analysts indicates a potential upside of 56.8% in Palantir Technologies (PLTR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wolfe Research says AT&T stock is worth buying after Q2 earnings. Analyst Peter Supino explained his bullish view on T shares in a research note.

NuScale's valuation has reset, but its buy case still hinges on turning approved technology and project pipelines into contracts, financing and revenues.

SpaceX initiated, PayPal upgraded: Wall Street's top analyst calls

The U.S. Food and Drug Administration on Wednesday granted De Novo authorization for Johnson & Johnson’s OTTAVA Robotic Surgical System, marking the regulatory clearance of the world’s first table-integrated soft tissue robotic platform. The marketing clearance encompasses multiple general surgery...

Based on the average brokerage recommendation (ABR), Okta (OKTA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

The average brokerage recommendation (ABR) for Palantir Technologies (PLTR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

According to the average brokerage recommendation (ABR), one should invest in Disney (DIS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 13.8% year on year to $872.3 million. Guidance for next quarter’s revenue was better than expected at $827.5 million at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $2.37 per share was 13.9% above analysts’ consensus estimates.